Publication details
DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021
| Authors | |
|---|---|
| Year of publication | 2021 |
| MU Faculty or unit | |
| Web | GastroPet |
| Description | Clinical Trial GastroPET EudraCT: 2017-001264-38 The clinical trial interim report describes the course and current status of the clinical trial (KH) in a defined period. It includes information on document updates, changes in KH centers and examiners, an overview of previously included/completed subjects of evaluation, and detected protocol violations. It also contains information on investigational medicine (reporting serious adverse events, suspicions of serious (unexpected) adverse events, or new findings in relation to safety and efficacy), new measures taken, and audits performed. |
| Related projects: |